223 related articles for article (PubMed ID: 18654415)
1. A little knowledge.
Nat Nanotechnol; 2007 Dec; 2(12):731. PubMed ID: 18654415
[No Abstract] [Full Text] [Related]
2. Scientists worry about some risks more than the public.
Scheufele DA; Corley EA; Dunwoody S; Shih TJ; Hillback E; Guston DH
Nat Nanotechnol; 2007 Dec; 2(12):732-4. PubMed ID: 18654416
[No Abstract] [Full Text] [Related]
3. The economy of promises.
Jones R
Nat Nanotechnol; 2008 Feb; 3(2):65-6. PubMed ID: 18654457
[No Abstract] [Full Text] [Related]
4. Indefinite particles.
Toumey C
Nat Nanotechnol; 2008 Jul; 3(7):372-3. PubMed ID: 18654552
[No Abstract] [Full Text] [Related]
5. Small advances.
Goldston D
Nature; 2007 Dec; 450(7173):1141. PubMed ID: 18097369
[No Abstract] [Full Text] [Related]
6. NANOtechnology: untold promise, unknown risk.
Consum Rep; 2007 Jul; 72(7):40-5. PubMed ID: 17632953
[No Abstract] [Full Text] [Related]
7. Talking biotech with the public.
Brauerhoch FO; Ewen C; Sinemus K
Biotechnol J; 2007 Sep; 2(9):1076-80. PubMed ID: 17703483
[TBL] [Abstract][Full Text] [Related]
8. Assets for mastering media relations.
Steinerman P
Nat Biotechnol; 2003 Jul; 21 Suppl():BE59-61. PubMed ID: 12874984
[No Abstract] [Full Text] [Related]
9. Talking with the public--challenging the public scare.
Sinemus K
Biotechnol J; 2007 Sep; 2(9):1047. PubMed ID: 17768765
[No Abstract] [Full Text] [Related]
10. Not in my makeup: the need for enhanced premarket regulatory authority over cosmetics in light of increased usage of engineered nanoparticles.
Johnson DR
J Contemp Health Law Policy; 2009; 26(1):82-124. PubMed ID: 20112620
[No Abstract] [Full Text] [Related]
11. Thinking small is not easy.
Batt CA
Nat Nanotechnol; 2008 Mar; 3(3):121-2. PubMed ID: 18654474
[No Abstract] [Full Text] [Related]
12. Perspective: Why communication in biotechnology is important.
Gassen HG
Biotechnol J; 2007 Sep; 2(9):1051-2. PubMed ID: 17768767
[No Abstract] [Full Text] [Related]
13. Communication of gene technology--a difficult enterprise: a journalist's view on biotech communication.
Spahl T; Deichmann T
Biotechnol J; 2007 Sep; 2(9):1064-6. PubMed ID: 17768770
[No Abstract] [Full Text] [Related]
14. Review of health safety aspects of nanotechnologies in food production.
Bouwmeester H; Dekkers S; Noordam MY; Hagens WI; Bulder AS; de Heer C; ten Voorde SE; Wijnhoven SW; Marvin HJ; Sips AJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):52-62. PubMed ID: 19027049
[TBL] [Abstract][Full Text] [Related]
15. Labeling of nanotechnology consumer products can influence risk and benefit perceptions.
Siegrist M; Keller C
Risk Anal; 2011 Nov; 31(11):1762-9. PubMed ID: 22084863
[TBL] [Abstract][Full Text] [Related]
16. Transparent communication strategy on GMOs: will it change public opinion?
Sinemus K; Egelhofer M
Biotechnol J; 2007 Sep; 2(9):1141-6. PubMed ID: 17703492
[TBL] [Abstract][Full Text] [Related]
17. Health information exchange and patient safety.
Kaelber DC; Bates DW
J Biomed Inform; 2007 Dec; 40(6 Suppl):S40-5. PubMed ID: 17950041
[TBL] [Abstract][Full Text] [Related]
18. Biotechnology and the popular press: hype and the selling of science.
Caulfield T
Trends Biotechnol; 2004 Jul; 22(7):337-9. PubMed ID: 15245905
[TBL] [Abstract][Full Text] [Related]
19. Animal cloning and the FDA--the risk assessment paradigm under public scrutiny.
Rudenko L; Matheson JC; Sundlof SF
Nat Biotechnol; 2007 Jan; 25(1):39-43. PubMed ID: 17211392
[TBL] [Abstract][Full Text] [Related]
20. Making the case for molecular imaging.
Schick M
J Nucl Med; 2008 Jun; 49(6):75N-77N. PubMed ID: 18511837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
